People News

Johnson & Johnson added Anne Mulcahy, chairman of the board of Xerox, to its board. Mulcalhy spent eight years as CEO of Xerox, retiring last July.

Peregrine Pharmaceuticals hired Dr. Robert Garnick as head of regulatory affairs. Dr. Garnick was formerly senior vice president for regulatory, quality and compliance at Genentech. During his 24-year career at Genentech, he was responsible for 17 new product approvals, including most of the company's top selling monoclonal antibody therapeutics such as Rituxan, Herceptin, Avastin and Lucentis.
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.